Clearance Summary
NML 6000 CT received FDA 510(k) clearance under submission number K823679, sponsored by Nuclear Medical Laboratories, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 1983-01-07.
- Submission: K823679
- Applicant / Sponsor: Nuclear Medical Laboratories, Inc.
- Clearance pathway: Traditional
- Review panel: Clinical Chemistry
- Device class: Class I
- Regulation citation: 21 CFR 862.2100
- Decision date: 1983-01-07
Classification & Regulation
This clearance is catalogued under FDA product code JQP and 21 CFR 862.2100, within the Clinical Chemistry review panel as a Class I device.